Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase

Haematologica. 2014 Mar;99(3):570-8. doi: 10.3324/haematol.2013.084533. Epub 2013 Sep 13.

Abstract

High counts of circulating microparticles, originated from the membrane of abnormal erythrocytes, have been associated with increased thrombotic risk in hemolytic disorders. Our studies indicate that in thalassemia intermedia patients the number of circulating microparticles correlates with the capability of the thalassemic erythrocytes to release microparticles. The microparticles are characteristically loaded with hemichromes formed by denatured α-chains. This finding was substantiated by the positive correlation observed in thalassemia intermedia patients between the amount of hemichromes measured in erythrocytes, their capability to release microparticles and the levels of plasma hemichromes. We observed that hemichromes, following their binding to the cytoplasmic domain of band 3, induce the formation of disulfide band 3 dimers that are subsequently phosphorylated by p72Syk kinase. Phosphorylation of oxidized band 3 appears to be relevant for the formation of large hemichromes/band 3 clusters that, in turn, induce local membrane instability and the release of microparticles. Proteomic analysis of microparticles released from thalassemia intermedia erythrocytes indicated that, besides hemichromes and clustered band 3, the microparticles contain a characteristic set of proteins that includes catalase, heat shock protein 70, peroxiredoxin 2 and carbonic anhydrase. High amounts of immunoglobulins and C3 have also been found to be associated with microparticles, accounting for their intense phagocytosis. The effect of p72Syk kinase inhibitors on the release of microparticles from thalassemia intermedia erythrocytes may indicate new perspectives for controlling the release of circulating microparticles in hemolytic anemias.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell-Derived Microparticles / metabolism*
  • Enzyme Activation
  • Erythrocytes / drug effects
  • Erythrocytes / metabolism*
  • Hemeproteins / metabolism*
  • Humans
  • Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Oxidation-Reduction
  • Phosphorylation
  • Protein Kinase Inhibitors / pharmacology
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism*
  • Syk Kinase
  • Thalassemia / blood
  • Thalassemia / metabolism*

Substances

  • Hemeproteins
  • Intracellular Signaling Peptides and Proteins
  • Protein Kinase Inhibitors
  • hemichrome
  • Protein-Tyrosine Kinases
  • SYK protein, human
  • Syk Kinase